Greimel Felix, Weber Markus, Renkawitz Tobias, Voellner Florian, Freude Thomas, Grifka Joachim, Craiovan Benjamin
Department of Orthopedics, University Medical Center Regensburg, Regensburg, Germany.
Department of Orthopedics and Traumatology, University Medical Center Salzburg, Salzburg, Austria.
J Orthop Surg (Hong Kong). 2020 Jan-Apr;28(1):2309499020908721. doi: 10.1177/2309499020908721.
The exact reconstruction of the tibial plateau and articular surface is the main operative aim in the treatment of tibial plateau depression fractures. For selected cases, a novel technique with the use of balloon tibioplasty in combination of bioabsorbable calcium phosphate cement is available. In this study, the first objective was to answer the question whether the clinical outcome parameters after balloon tibioplasty are comparable to open reduction procedures described in the literature. Secondly, we asked whether the cement absorption is safe in relation to adverse effects like osteolysis and measured the absorption ability during the bone conversion process in the proximal tibia bone. Eight patients (mean age 54 years; 4 males and 4 females) received the abovementioned surgical procedure. Mean follow-up period was 27 months. This study evaluated clinical outcome and radiological measured cement absorption within the postoperative course. Cement absorption was measured on X-rays and calculated based on the greatest extend on anterior-posterior and lateral view radiographs just after the operation on the latest available follow-up. WOMAC score showed a mean of 93. Radiologic absorption was 1/5 at a mean of 18 months. No osteolysis reaction was seen surrounding the cement. This far, promising clinical and radiological results have been shown with WOMAC scores comparable to the results of noninjured knees. The indication for this relatively new technique is restricted to isolated depression fractures. It is a useful tool to facilitate the reduction of select depressed tibial fractures. The radiologic absorption effect seems to be quite fast in bone remodeling and safe without any osteolysis or osseous reaction.
胫骨平台和关节面的精确重建是治疗胫骨平台凹陷骨折的主要手术目标。对于特定病例,可采用一种新型技术,即球囊胫骨成形术联合生物可吸收磷酸钙骨水泥。在本研究中,首要目的是回答球囊胫骨成形术后的临床结果参数是否与文献中描述的切开复位手术相当。其次,我们探讨了骨水泥吸收在诸如骨溶解等不良反应方面是否安全,并测量了胫骨近端骨在骨转换过程中的吸收能力。8例患者(平均年龄54岁;4例男性,4例女性)接受了上述手术。平均随访期为27个月。本研究评估了术后过程中的临床结果和通过影像学测量的骨水泥吸收情况。通过X线片测量骨水泥吸收,并根据术后即刻及最新可用随访时前后位和侧位X线片上的最大范围进行计算。WOMAC评分为93分。平均18个月时影像学吸收为1/5。在骨水泥周围未见骨溶解反应。到目前为止,已显示出有前景的临床和影像学结果,WOMAC评分与未受伤膝关节的结果相当。这种相对新技术的适应证仅限于孤立性凹陷骨折。它是促进特定凹陷性胫骨骨折复位的有用工具。影像学吸收效应在骨重塑过程中似乎相当快且安全,无任何骨溶解或骨反应。